Skip to main content
. 2023 Oct 6;72(40):1075–1082. doi: 10.15585/mmwr.mm7240a1

FIGURE 1.

Figure is a bar graph indicating underlying medical conditions among U.S. patients in 12 states hospitalized with laboratory-confirmed respiratory syncytial virus infection during October 2022–April 2023, based on data from the Respiratory Syncytial Virus–Associated Hospitalization Surveillance Network.

Underlying medical conditions*, among patients hospitalized with laboratory-confirmed respiratory syncytial virus infection§ — Respiratory Syncytial Virus–Associated Hospitalization Surveillance Network, 12 states, October 2022–April 2023

Abbreviation: COPD = chronic obstructive pulmonary disease.

* With 95% CIs indicated by error bars.

Congestive heart failure includes cardiomyopathy; coronary artery disease includes history of coronary artery bypass graft and myocardial infarction; cerebrovascular accident includes history of stroke or transient ischemic attack; dementia includes Alzheimer disease and other types of dementia.

§ Data are from a weighted sample of hospitalized adults with completed medical record abstractions. Sample sizes presented are unweighted with weighted percentages.

Select counties in California, Colorado, Connecticut, Georgia, Maryland, Michigan, Minnesota, New Mexico, New York, Oregon, Tennessee, and Utah.